cyclosporine + methylprednisolone

Cyclosporine + methylprednisolone is a combination of two immunosuppressive drugs used primarily for the treatment of autoimmune diseases and in organ transplantation. Cyclosporine is a calcineurin inhibitor that suppresses T-cell mediated immune responses by inhibiting the activity of calcineurin, thereby reducing interleukin-2 production and T-cell proliferation. Methylprednisolone is a synthetic glucocorticoid corticosteroid that exerts anti-inflammatory and immunosuppressive effects by modulating gene expression to decrease the production of pro-inflammatory cytokines and mediators. This combination has been studied as second-line therapy for conditions such as severe alopecia areata, systemic lupus erythematosus (SLE), and for prevention or treatment of graft-versus-host disease (GVHD) after transplantation. The rationale behind combining these agents is to achieve synergistic immunosuppression while potentially allowing lower doses of each drug, which may reduce side effects compared to higher-dose monotherapy.